Standout Papers

Antitumor Activity of Thalidomide in Refractory Multiple Myeloma 1999 2026 2008 2017 1.9k
  1. Antitumor Activity of Thalidomide in Refractory Multiple Myeloma (1999)
    Seema Singhal, Jayesh Mehta et al. New England Journal of Medicine

Immediate Impact

2 by Nobel laureates 18 from Science/Nature 107 standout
Sub-graph 1 of 13

Citing Papers

Targeted protein degradation: from mechanisms to clinic
2024 Standout
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
43 intermediate papers

Works of Raman Desikan being referenced

Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy
2001
Antitumor Activity of Thalidomide in Refractory Multiple Myeloma
1999 Standout
and 7 more

Author Peers

Author Last Decade Papers Cites
Raman Desikan 3500 2604 1775 35 4.4k
Athanasios Fassas 4928 2875 2451 79 6.0k
R Ohno 4067 2152 1144 102 5.7k
David Irwin 2500 2490 2126 66 4.1k
Martin Hjorth 2328 1319 1194 45 3.5k
Jean‐Luc Harousseau 2558 2181 1608 42 3.3k
Patrizia Tosi 5103 3511 2956 143 6.4k
H M Lokhorst 2217 1635 1515 78 3.5k
Brendan M. Weiss 2744 2475 2138 94 4.7k
Kay Delasalle 2543 1673 1562 60 3.3k
Joth Jacobson 1571 1098 834 34 2.3k

All Works

Loading papers...

Rankless by CCL
2026